| Overview |
| bsm-90359r-50µL |
| HIF 1 β Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human HIF-1 beta |
| 450-789/789 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 405 |
| P27540 |
| ARNT; Aryl Hydrocarbon Receptor Nuclear Translocator ; BHLHe2; HIF-1beta; Class E Basic Helix-Loop-Helix Protein 2; Hypoxia Inducible Factor 1; Subunit Beta; Dioxin Receptor Nuclear Translocator; HIF-1-Beta; HIF1-Beta; ARNT1; Hypoxia-Inducible Factor 1 Beta Subunit; Hypoxia-Inducible Factor 1-Beta; ARNT Protein; HIF1BETA; BHLHE2; HIF1B; TANGO |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |